文献速递垂体与肾上腺疾病

同步游离皮质醇检测可提升地塞米松抑制试验异常结果判读

Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究在无肾上腺疾病的成人志愿者和接受高皮质醇评估的患者中,建立了地塞米松抑制试验(DST)后游离皮质醇的正常范围,并评估其与总皮质醇的诊断准确性。结果显示,总皮质醇的假阳性均出现在DST后总皮质醇1.8-5 mcg/dL的患者中,口服避孕药(OCP)是假阳性的唯一相关因素。结论认为,对于地塞米松浓度充足且总皮质醇处于1.8-5 mcg/dL的患者,检测游离皮质醇有价值。

要点

  • 无肾上腺疾病者DST后游离皮质醇上限:男性及未用OCP女性48 ng/dL,OCP女性79 ng/dL。
  • DST后总皮质醇诊断准确性87.3%,假阳性均见于总皮质醇1.8-5 mcg/dL者。
  • OCP使用是假阳性唯一相关因素(21.1% vs 4.9%,P=0.02)。

核心结论

  • 对于地塞米松浓度充足且DST后总皮质醇在1.8-5 mcg/dL的患者,检测游离皮质醇有助于提高异常结果判读的准确性。

研究设计与样本

  • 横断面研究,在三级医疗中心开展。
  • 纳入无肾上腺疾病成人志愿者168例(47例用OCP女性、66例未用OCP女性、55例男性)和接受高皮质醇评估的患者196例(16例用OCP女性)。

主要发现

  • 地塞米松浓度充足(≥0.1 mcg/dL)者中,志愿者占97.6%,患者占96.3%。
  • 使用OCP的女性志愿者中仅25.5%出现DST后总皮质醇异常(>1.8 mcg/dL)。
  • DST后总皮质醇诊断准确性为87.3%(95% CI,81.7-91.7),假阳性均见于总皮质醇1.8-5 mcg/dL者。
  • OCP使用是假阳性的唯一相关因素(21.1% vs 4.9%,P=0.02)。

关键数值与推荐

  • 志愿者DST后游离皮质醇上限:男性和未用OCP女性为48 ng/dL,用OCP女性为79 ng/dL。
  • DST后总皮质醇异常定义为>1.8 mcg/dL。
  • 地塞米松浓度充足定义为≥0.1 mcg/dL。

临床怎么用

  • 在DST后总皮质醇处于1.8-5 mcg/dL且地塞米松浓度充足时,可加测游离皮质醇以区分假阳性。
  • 对使用口服避孕药的患者,解读DST结果时应考虑游离皮质醇检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Interpretation of dexamethasone suppression test (DST) may be influenced by dexamethasone absorption and metabolism and by the altered cortisol binding. OBJECTIVE: We aimed to determine the normal ranges of free cortisol during DST in participants without adrenal disorders and to identify the population of patients where post-DST free cortisol measurements add value to the diagnostic workup. DESIGN AND SETTING: Cross-sectional study conducted in a tertiary medical center. PARTICIPANTS: Adult volunteers without adrenal disorders (n = 168; 47 women on oral contraceptive therapy [OCP], 66 women not on OCP, 55 men) and patients undergoing evaluation for hypercortisolism (n = 196; 16 women on OCP). MEASUREMENTS: Post-DST dexamethasone and free cortisol (mass spectrometry) and total cortisol (immunoassay). MAIN OUTCOME MEASURES: Reference range for post-DST free cortisol, diagnostic accuracy of post-DST total cortisol. RESULTS: Adequate dexamethasone concentrations (≥0.1 mcg/dL) were seen in 97.6% volunteers and 96.3% patients. Only 25.5% of women volunteers on OCP had abnormal post-DST total cortisol (>1.8 mcg/dL). In volunteers, the upper post-DST free cortisol range was 48 ng/dL in men and women not on OCP, and 79 ng/dL in women on OCP. When compared with post-DST free cortisol, diagnostic accuracy of post-DST total cortisol was 87.3% (95% CI, 81.7-91.7); all false-positive results occurred in patients with post-DST cortisol between 1.8 and 5 mcg/dL. OCP use was the only factor associated with false-positive results (21.1% vs 4.9%, P = 0.02). CONCLUSIONS: Post-DST free cortisol measurements are valuable in patients with optimal dexamethasone concentrations and post-DST total cortisol between 1.8 and 5 mcg/dL.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Genere N, Kaur RJ, Athimulam S, et al. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment. J Clin Endocrinol Metab. 2022. PMID: 34648626. doi:10.1210/clinem/dgab724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。